Thalidomide Survivors Contribution Program

Welcome to the website for the Thalidomide Survivors Contribution Program. The purpose of this website is to provide visitors with information and updates relating to the program.


In spring 2015, a federal support package for Canadian Thalidomide Survivors was announced. The support package includes:




Ongoing Support PaymentsIf your health has gotten worse as a result of Thalidomide since the 1991 assessment or since your last TSCP assessmentIf you did not receive a payment from the Extraordinary Assistance Plan in 1991Extraordinary Medical Assistance Fund (“EMAF”)The Ongoing Support Payment for the 2018-2019 FY will be issued in April of 2018. If you wish to change how you are receiving your annual Ongoing Support Payment, please complete and submit a new Ongoing Support Payment form and check the “Change Requested” box on the first page of the form. The change will take effect starting with the next Ongoing Support Payment following approval of the form once submitted. The Ongoing Support Payment for the 2019-2020 FY will be issued in April of 2019.Reassessment may be requested once per year between April 1st of the current year and March 31st of the next year unless there is an urgent need. Urgent requests will be reviewed on a case by case basis to decide if the request will be granted. Any increase to a Survivor’s Ongoing Support Payment amount as a result of a change in disability level would take effect April 1st of the next Fiscal Year. If you wish to request reassessment, please complete and submit a Reassessment form.We are aware that on February 27, 2018, Budget 2018 announced that the TSCP would be expanded to address the possibility that some thalidomide survivors may have been excluded by the current eligibility criteria. While we do not have any additional information, Budget 2018 indicated that further details may be announced in the spring. We expect that this announcement will also indicate when claimants can begin to apply to the Program.Confirmed Canadian Thalidomide Survivors have access to the EMAF which is intended to help cover the cost of extraordinary health support costs of Canadian Thalidomide Survivors with needs such as specialized surgeries or home or vehicle adaptations. For the 2018-2019 fiscal year, you may submit your application anytime between April 1, 2018 and March 31, 2019. If you wish to request EMAF funding, please complete and submit an EMAF Application. For more information about the EMAF, please click here.











Crawford & Company (Canada) Inc. is funded by Health Canada to deliver the Government of Canada’s Thalidomide Survivors Contribution Program. The views expressed herein do not necessarily represent the views of Health Canada.